Efficacy of febuxostat in hyperuricemic patients with mild-to-moderate chronic kidney disease: a meta-analysis of randomized clinical trials: A PRISMA-compliant article

BACKGROUND: To investigate the efficacy of febuxostat in hyperuricemic patients with chronic kidney disease (CKD), relevant randomized clinical trials (RCTs) were analyzed. METHODS: We used PubMed, Medline, ISI Web of Science, CBMdisc, and Cochrane Library databases to conduct a systematic literatur...

Descripción completa

Detalles Bibliográficos
Autores principales: Zeng, Xiang Xia, Tang, Yunliang, Hu, Kaixiang, Zhou, Xi, Wang, Jiao, Zhu, Lingyan, Liu, Jianying, Xu, Jixiong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2018
Materias:
4200
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5895369/
https://www.ncbi.nlm.nih.gov/pubmed/29595642
http://dx.doi.org/10.1097/MD.0000000000010161

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5895369/
https://www.ncbi.nlm.nih.gov/pubmed/29595642
http://dx.doi.org/10.1097/MD.0000000000010161

Ejemplares similares